151 related articles for article (PubMed ID: 6209142)
1. Progress in chemotherapy of non-small cell lung cancer.
Sculier JP; Klastersky J
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1329-33. PubMed ID: 6209142
[TBL] [Abstract][Full Text] [Related]
2. [Current perspectives in the management of non-small cell lung cancer].
Fujita J; Saijo N
Gan No Rinsho; 1985 Apr; 31(4):355-62. PubMed ID: 2409308
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of non-small cell lung cancer: a reappraisal and a look to the future.
Bakowski MT; Crouch JC
Cancer Treat Rev; 1983 Sep; 10(3):159-72. PubMed ID: 6311415
[No Abstract] [Full Text] [Related]
4. Management of non-small-cell cancer.
Soukop M
Recent Results Cancer Res; 1984; 92():79-88. PubMed ID: 6204364
[No Abstract] [Full Text] [Related]
5. Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.
Klastersky J; Sculier JP; Nicaise C; Weerts D; Mairesse M; Libert P; Rocmans P; Michel J; Ferremans W
Cancer Treat Rep; 1983; 67(7-8):727-30. PubMed ID: 6347374
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of advanced non-small cell lung cancer. A review.
Takasugi BJ; Miller TP
Invest New Drugs; 1984; 2(3):339-47. PubMed ID: 6392149
[No Abstract] [Full Text] [Related]
7. A prospective randomized trial of combination vindesine and cisplatin versus single-agent vindesine in advanced non-small cell lung cancer.
Popkin JD; Hong WK; Cersosimo RJ; Faling LJ; Snow MN; Fofonoff SA
Pharmacotherapy; 1985; 5(1):20-2. PubMed ID: 3885173
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.
Dhingra HM; Valdivieso M; Carr DT; Chiuten DF; Farha P; Murphy WK; Spitzer G; Umsawasdi T
J Clin Oncol; 1985 Feb; 3(2):176-83. PubMed ID: 2981982
[TBL] [Abstract][Full Text] [Related]
9. [Antineoplastic chemotherapy for bronchial carcinoma].
Tanneberger S
Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer.
Itri LM; Gralla RJ; Kelsen DP; Chapman RA; Casper ES; Braun DW; Howard JE; Golbey R; Heelan RT
Cancer; 1983 Mar; 51(6):1050-5. PubMed ID: 6185210
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
Ruckdeschel JC; Finkelstein DM; Ettinger DS; Creech RH; Mason BA; Joss RA; Vogl S
J Clin Oncol; 1986 Jan; 4(1):14-22. PubMed ID: 3510278
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
Havemann K
Cancer Treat Rev; 1982 Jun; 9 Suppl():95-100. PubMed ID: 6290059
[No Abstract] [Full Text] [Related]
13. Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study.
Elliott JA; Ahmedzai S; Hole D; Dorward AJ; Stevenson RD; Kaye SB; Banham SW; Stack BH; Calman KC
Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1025-32. PubMed ID: 6540685
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of esophageal cancer.
Kelsen D
Semin Oncol; 1984 Jun; 11(2):159-68. PubMed ID: 6203176
[No Abstract] [Full Text] [Related]
15. [3 multicenter phase II studies of the treatment of small cell bronchogenic carcinoma (incl. AIO studies BI + BII)].
Liesenfeld A; Havemann K; Gropp C; Seifert W; Thomas C; Drings P; Mahnke HG; Westerhausen M; Wellens W; Konrad RM
Onkologie; 1984 Jun; 7(3):145-51. PubMed ID: 6087231
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
[TBL] [Abstract][Full Text] [Related]
17. Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologies.
Muggia FM; Blum RH; Foreman JD
Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):137-45. PubMed ID: 6365863
[TBL] [Abstract][Full Text] [Related]
18. Warfarin, etoposide, and vindesine interactions.
Ward K; Bitran JD
Cancer Treat Rep; 1984 May; 68(5):817-8. PubMed ID: 6539172
[No Abstract] [Full Text] [Related]
19. [Small cell bronchial cancer. Comparison of results of weekly polychemotherapy using multiple drugs with standard chemotherapy. European Lung Cancer Working Party].
Sculier JP; Paesmans M; Bureau G; Dabouis G; Libert P; Vandermoten G; Van Cutsem O; Berchier MC; Ries F; Michel J
Rev Mal Respir; 1994; 11(3):257-61. PubMed ID: 8041988
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of metastatic non-small cell bronchogenic carcinoma.
Hoffman PC; Bitran JD; Golomb HM
Semin Oncol; 1983 Mar; 10(1):111-22. PubMed ID: 6301062
[No Abstract] [Full Text] [Related]
[Next] [New Search]
